The following information was provided by the
Kentucky Department for Public Health (the Department) via email:
On 4/24/2025, permanent implant brachytherapy (isotope unknown at this time) was administered without a written directive. A pre-treatment plan was completed and approved by the authorized user (AU), and treatment was administered on this basis by the AU, but no pre-implant or post-implant written directives meeting the requirements of 10 CFR 35 were completed. The event was identified during the post implant dosimetry process on 5/6/2025.
This event is under investigation. University of Kentucky has temporarily paused implants while they complete their assessment and implement corrective actions.
The written report will follow as required in 15 days. A reactive inspection will be performed by the Department.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.